Prognostic value of serum albumin for long-term mortality in patients with dual-chamber permanent pacemakers

This investigation aims to examine the prognostic utility of albumin concentrations for long-term all-cause mortality in patients undergoing permanent pacemaker implantation. A total of 1798 patients who received permanent pacemaker implantation were divided into quartiles according to serum albumin...

Full description

Saved in:
Bibliographic Details
Published in:Biomarkers in medicine 2022-04, Vol.16 (5), p.341-348
Main Authors: Hayıroğlu, Mert İlker, Çınar, Tufan, Çinier, Göksel, Yüksel, Gizem, Pay, Levent, Keskin, Kıvanç, Coşkun, Cahit, Ayan, Gökçem, Çiçek, Vedat, Tekkeşin, Ahmet İlker
Format: Article
Language:English
Subjects:
albumin
dual-chamber pacemaker
Humans
long-term mortality
pacemaker
Pacemaker, Artificial - adverse effects
Prognosis
Serum Albumin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This investigation aims to examine the prognostic utility of albumin concentrations for long-term all-cause mortality in patients undergoing permanent pacemaker implantation. A total of 1798 patients who received permanent pacemaker implantation were divided into quartiles according to serum albumin concentrations. The significance of albumin in predicting long-term mortality was compared in these quartiles. There was a higher rate of long-term mortality in the Q4 group compared with the Q1–3 groups (49.9 vs 15.8%). The risk of long-term mortality in the Q4 group was 3.6-times higher compared with the Q1–3 groups after adjustment for confounders. Serum albumin level at the time of device implantation has great value when assessing long-term mortality in patients with permanent pacemakers.
ISSN:1752-0363
1752-0371
DOI:10.2217/bmm-2021-0991